ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

BIOG Biotech Growth Trust (the) Plc

991.00
1.00 (0.10%)
Last Updated: 15:46:34
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Biotech Growth Trust (the) Plc LSE:BIOG London Ordinary Share GB0000385517 ORD 25P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  1.00 0.10% 991.00 984.00 988.00 999.00 984.00 999.00 14,450 15:46:34
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Unit Inv Tr, Closed-end Mgmt -32.42M -41.3M -1.0034 -9.88 407.88M

The Biotech Growth Trust Plc - Issue of Equity

22/04/2021 4:53pm

PR Newswire (US)


Biotech Growth (LSE:BIOG)
Historical Stock Chart


From May 2019 to May 2024

Click Here for more Biotech Growth Charts.

THE BIOTECH GROWTH TRUST PLC

22 April 2021

Allotment of Ordinary Shares

THE BIOTECH GROWTH TRUST PLC (the “Company”) announces the allotment of 30,000 Ordinary shares of 25p each fully paid from its block listing authority. 

These shares were issued today at a price of 1425.50 pence per Ordinary share, which equates to a premium to the estimated ex income net asset value per Ordinary share at the time of transaction of 1%. The ex income net asset value per Ordinary share at the close of business on 21 April 2021 was 1407.09 pence.

Following this issue, the Company has the ability to issue a further 3,600,634 Ordinary shares its block listing facility.

Following this transaction the Company hereby notifies the market that it has in issue 41,664,769 Ordinary shares of 25p each all with voting rights.  No shares were held in treasury at the date of announcement.

The figure of 41,664,769 may be used by shareholders as the denominator for the calculation by which they may determine if they are required to notify their interest in, or change to their interest in, the Company under the FCA’s Disclosure Guidance and Transparency Rules.

Enquiries:
Mark Pope                
Frostrow Capital LLP           
Tel: 020 3 008 4913

Copyright l 22 PR Newswire

1 Year Biotech Growth Chart

1 Year Biotech Growth Chart

1 Month Biotech Growth Chart

1 Month Biotech Growth Chart

Your Recent History

Delayed Upgrade Clock